Orion Oyj Logo

Orion Oyj

Develops, manufactures, and markets human and veterinary pharmaceuticals and APIs.

ORNAV | HE

Overview

Corporate Details

ISIN(s):
FI0009014377 (+1 more)
LEI:
74370029VAHCXDR7B745
Country:
Finland
Address:
Orionintie 1, FI-02200 ESPOO

Description

Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2011-10-25 10:01
Orion Group Interim Report January-September 2011
English DOC 1022.4 KB
2011-10-25 10:01
Orion-konsernin osavuosikatsaus kaudelta 1-9/2011
Finnish DOC 963.1 KB
2011-10-11 06:35
Orion invites analysts and media to Q3 news conference on Tuesday 25 October 20…
English DOC 2.8 KB
2011-10-11 06:35
Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 2…
Finnish DOC 2.9 KB
2011-09-26 11:25
Disclosure Under Chapter 2 Section 10
English DOC 2.9 KB
2011-09-26 11:25
Arvopaperimarkkinalain 2 luvun 10 §:n mukainen liputusilmoitus
Finnish DOC 2.9 KB
2011-09-23 06:45
400,000 Orion A-shares converted into B-shares
English DOC 1.8 KB
2011-09-23 06:45
400 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish DOC 1.7 KB
2011-08-19 07:00
136,231 Orion A-shares converted into B-shares
English DOC 1.8 KB
2011-08-19 07:00
136 231 Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish DOC 1.7 KB
2011-08-02 10:00
Orion Group Interim Report January-June 2011
English DOC 1.0 MB
2011-08-02 10:00
Orion-konsernin osavuosikatsaus kaudelta 1-6/2011
Finnish DOC 947.3 KB
2011-07-22 08:55
Euroopan lääkeviraston ihmislääkekomitealta (CHMP) myönteinen lausunto Orionin …
Finnish DOC 3.0 KB
2011-07-22 08:55
Orion receives positive CHMP opinion for new intensive care sedative, dexdor® (…
English DOC 3.0 KB
2011-06-22 06:45
100,000 Orion A-shares converted into B-shares
English DOC 1.0 KB

Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Orion Oyj

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Orion Oyj via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.